231 related articles for article (PubMed ID: 16410551)
1. Nitric oxide mediates neurodegeneration and breakdown of the blood-brain barrier in tPA-dependent excitotoxic injury in mice.
Parathath SR; Parathath S; Tsirka SE
J Cell Sci; 2006 Jan; 119(Pt 2):339-49. PubMed ID: 16410551
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide synthase isoforms undertake unique roles during excitotoxicity.
Parathath SR; Gravanis I; Tsirka SE
Stroke; 2007 Jun; 38(6):1938-45. PubMed ID: 17446423
[TBL] [Abstract][Full Text] [Related]
3. iNOS-derived NO and nox2-derived superoxide confer tolerance to excitotoxic brain injury through peroxynitrite.
Kawano T; Kunz A; Abe T; Girouard H; Anrather J; Zhou P; Iadecola C
J Cereb Blood Flow Metab; 2007 Aug; 27(8):1453-62. PubMed ID: 17293848
[TBL] [Abstract][Full Text] [Related]
4. Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator.
Tsirka SE; Gualandris A; Amaral DG; Strickland S
Nature; 1995 Sep; 377(6547):340-4. PubMed ID: 7566088
[TBL] [Abstract][Full Text] [Related]
5. Regulation of seizure spreading by neuroserpin and tissue-type plasminogen activator is plasminogen-independent.
Yepes M; Sandkvist M; Coleman TA; Moore E; Wu JY; Mitola D; Bugge TH; Lawrence DA
J Clin Invest; 2002 Jun; 109(12):1571-8. PubMed ID: 12070304
[TBL] [Abstract][Full Text] [Related]
6. Cell type-specific roles for tissue plasminogen activator released by neurons or microglia after excitotoxic injury.
Siao CJ; Fernandez SR; Tsirka SE
J Neurosci; 2003 Apr; 23(8):3234-42. PubMed ID: 12716930
[TBL] [Abstract][Full Text] [Related]
7. Modulation of zinc toxicity by tissue plasminogen activator.
Siddiq MM; Tsirka SE
Mol Cell Neurosci; 2004 Jan; 25(1):162-71. PubMed ID: 14962749
[TBL] [Abstract][Full Text] [Related]
8. Tissue plasminogen activator as a modulator of neuronal survival and function.
Tsirka SE
Biochem Soc Trans; 2002 Apr; 30(2):222-5. PubMed ID: 12023855
[TBL] [Abstract][Full Text] [Related]
9. Neuronal death and blood-brain barrier breakdown after excitotoxic injury are independent processes.
Chen ZL; Indyk JA; Bugge TH; Kombrinck KW; Degen JL; Strickland S
J Neurosci; 1999 Nov; 19(22):9813-20. PubMed ID: 10559390
[TBL] [Abstract][Full Text] [Related]
10. 2,7-Bis-(4-amidinobenzylidene)-cycloheptan-1-one dihydrochloride, tPA stop, prevents tPA-enhanced excitotoxicity both in vitro and in vivo.
Liot G; Benchenane K; Léveillé F; López-Atalaya JP; Fernández-Monreal M; Ruocco A; Mackenzie ET; Buisson A; Ali C; Vivien D
J Cereb Blood Flow Metab; 2004 Oct; 24(10):1153-9. PubMed ID: 15529015
[TBL] [Abstract][Full Text] [Related]
11. The intranigral injection of tissue plasminogen activator induced blood-brain barrier disruption, inflammatory process and degeneration of the dopaminergic system of the rat.
Villarán RF; de Pablos RM; Argüelles S; Espinosa-Oliva AM; Tomás-Camardiel M; Herrera AJ; Cano J; Machado A
Neurotoxicology; 2009 May; 30(3):403-13. PubMed ID: 19442825
[TBL] [Abstract][Full Text] [Related]
12. Pentylentetrazole-induced loss of blood-brain barrier integrity involves excess nitric oxide generation by neuronal nitric oxide synthase.
Danjo S; Ishihara Y; Watanabe M; Nakamura Y; Itoh K
Brain Res; 2013 Sep; 1530():44-53. PubMed ID: 23831997
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide redox species exert differential permeability effects on the blood-brain barrier.
Boje KM; Lakhman SS
J Pharmacol Exp Ther; 2000 May; 293(2):545-50. PubMed ID: 10773027
[TBL] [Abstract][Full Text] [Related]
14. Tissue-type plasminogen activator crosses the intact blood-brain barrier by low-density lipoprotein receptor-related protein-mediated transcytosis.
Benchenane K; Berezowski V; Ali C; Fernández-Monreal M; López-Atalaya JP; Brillault J; Chuquet J; Nouvelot A; MacKenzie ET; Bu G; Cecchelli R; Touzani O; Vivien D
Circulation; 2005 May; 111(17):2241-9. PubMed ID: 15851587
[TBL] [Abstract][Full Text] [Related]
15. The neurotoxicity of tissue plasminogen activator?
Kaur J; Zhao Z; Klein GM; Lo EH; Buchan AM
J Cereb Blood Flow Metab; 2004 Sep; 24(9):945-63. PubMed ID: 15356416
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotection by urokinase plasminogen activator in the hippocampus.
Cho E; Lee KJ; Seo JW; Byun CJ; Chung SJ; Suh DC; Carmeliet P; Koh JY; Kim JS; Lee JY
Neurobiol Dis; 2012 Apr; 46(1):215-24. PubMed ID: 22293605
[TBL] [Abstract][Full Text] [Related]
17. eNOS gene deletion restores blood-brain barrier integrity and attenuates neurodegeneration in the thiamine-deficient mouse brain.
Beauchesne E; Desjardins P; Hazell AS; Butterworth RF
J Neurochem; 2009 Oct; 111(2):452-9. PubMed ID: 19686244
[TBL] [Abstract][Full Text] [Related]
18. Blood brain barrier (BBB) dysfunction associated with increased expression of tissue and urokinase plasminogen activators following peripheral thermal injury.
Patel TH; Sprague S; Lai Q; Jimenez DF; Barone CM; Ding Y
Neurosci Lett; 2008 Oct; 444(3):222-6. PubMed ID: 18718505
[TBL] [Abstract][Full Text] [Related]
19. Adiponectin protects hippocampal neurons against kainic acid-induced excitotoxicity.
Jeon BT; Shin HJ; Kim JB; Kim YK; Lee DH; Kim KH; Kim HJ; Kang SS; Cho GJ; Choi WS; Roh GS
Brain Res Rev; 2009 Oct; 61(2):81-8. PubMed ID: 19460404
[TBL] [Abstract][Full Text] [Related]
20. Microglial activation and recruitment, but not proliferation, suffice to mediate neurodegeneration.
Rogove AD; Lu W; Tsirka SE
Cell Death Differ; 2002 Aug; 9(8):801-6. PubMed ID: 12107823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
